Skip to content

Epigenetic Station

Epigenetic Resource and Protocol Centre

Menu
  • Home
  • Sequencing of Sodium
  • Treatment of Cells
  • DNA METHYLATION
  • DNA Methylation
Menu

CpG Island

Posted on December 29, 2022

Cytosine methylation of DNA at CpG dinucleotides is the most well-known epigenetic change. Less than 10% of all cytosines are methylated in the human genome (1). These CpG dinucleotides are also not found randomly throughout the genome, but in finite areas, specifically clustered at the 5′ region of genes, in the promoter, untranslated region, and exon 1. These CpG islands are not methylated in normal cells, thereby allowing for transcription of the genes through allowing access of the transcription machinery to the DNA.

However, in cancer cells, these CpG dinucleotides found within these CpG islands is targeted and hypermethylated, thereby preventing any transcription activators to access the DNA. This is known as silencing and often occurs on tumor-suppressor genes leading to tumorigenesis. Tumor-suppressor genes have an open chromatin conformation, with promoter CpG island hypomethylation.

CpG island hypermethylation closes the chromatin conformation through condensation and packaging, thereby allowing the cell entry in the cycle without regulation and avoidance of cell death. Interestingly, in tumor cells, gene-specific 5′ region CpG’s are highly methylated, while the rest of the genome becomes highly unmethylated. This may be due to repetitive sequences and genome stability, and tumor cells exhibit genome fragility and chromatin instability.

References:

(1). Estellier M. 2005. Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol. 45, 629-656

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Breakthroughs in Glycosylation Pathways: Defining the Progress of Biotechnological Production and Therapeutic Development
  • The Rise of Glycobiology: Developing Tailored Therapies Through Glycan Analysis and Profiling
  • Investigating Glycosylation Patterns with MS Analysis: A transformative development in Bioconjugation Techniques and Drug Discovery
  • Exploring Carbohydrate-Protein Interaction Platforms: Transforming Therapeutic Innovation and Innovation
  • Navigating Carbohydrate-Protein Interaction Platforms: Revolutionizing Drug Discovery and Breakthroughs

Recent Comments

No comments to show.

Archives

  • May 2025
  • April 2025
  • January 2025
  • February 2024
  • December 2022

Categories

  • Blog
  • Uncategorized
©2025 Epigenetic Station | WordPress Theme by Superbthemes.com